Related Experiment Video
Updated: Oct 7, 2025
11:57
Scaffold-supported Transplantation of Islets in the Epididymal Fat Pad of Diabetic Mice
Published on: July 23, 2017
10.3K
Biomaterial Applications in Islet Encapsulation and Transplantation
Julia S Caserto1, Daniel T Bowers1, Kaavian Shariati1
1Department of Biological and Environmental Engineering, Cornell University, Ithaca, New York 14853, United States.
ACS Applied Bio Materials
|January 12, 2022
Summary
Researchers are developing advanced cell encapsulation methods to overcome challenges in type 1 diabetes treatment, aiming to improve islet transplantation efficacy and patient convenience.
Area of Science:
- Biomedical Engineering
- Regenerative Medicine
- Materials Science
Background:
- Type 1 diabetes (T1D) prevalence necessitates improved treatments beyond current management.
- Islet transplantation offers a potential cure but faces donor scarcity and immunosuppression issues.
- Cell encapsulation for T1D treatment is hindered by foreign body responses, mass transfer limits, and scalability concerns.
Purpose of the Study:
- To address key challenges in cell encapsulation for T1D therapy.
- To develop innovative biomaterials and device designs for improved cell encapsulation.
- To enhance oxygen supply and vascularization for encapsulated cell survival and function.
Main Methods:
- Developing novel biomaterials to reduce foreign body responses and fibrosis.
- Engineering scalable and retrievable encapsulation devices.
- Implementing strategies for oxygen supplementation and promoting vascularization.
Main Results:
- Demonstrated progress in mitigating immune rejection and fibrosis around implants.
- Developed functional, scalable encapsulation devices suitable for therapeutic applications.
- Showcased strategies to improve oxygen diffusion and vascular integration for enhanced cell viability.
Conclusions:
- Advanced biomaterials and device engineering are crucial for overcoming cell encapsulation hurdles in T1D.
- Scalable, retrievable encapsulation devices with improved oxygenation and vascularization hold promise for T1D treatment.
- These advancements pave the way for more effective and less invasive cell-based therapies for type 1 diabetes.
